- Report
- November 2025
- 187 Pages
Global
From €4007EUR$4,500USD£3,495GBP
- Report
- August 2025
- 183 Pages
Global
From €4007EUR$4,500USD£3,495GBP
- Report
- August 2025
- 180 Pages
Global
From €4007EUR$4,500USD£3,495GBP
- Report
- November 2025
- 200 Pages
Global
From €7080EUR$7,950USD£6,174GBP
- Report
- November 2025
- 200 Pages
Global
From €7080EUR$7,950USD£6,174GBP
- Report
- March 2026
- 400 Pages
Global
From €4407EUR$4,949USD£3,843GBP
- Report
- March 2026
- 150 Pages
Global
From €2404EUR$2,699USD£2,096GBP
- Report
- July 2025
- 350 Pages
Global
From €4407EUR$4,949USD£3,843GBP
- Report
- June 2025
- 150 Pages
Global
From €2404EUR$2,699USD£2,096GBP
- Report
- June 2025
- 150 Pages
Global
From €2404EUR$2,699USD£2,096GBP
- Drug Pipelines
- June 2025
- 200 Pages
Global
From €2484EUR$2,789USD£2,166GBP
- Drug Pipelines
- June 2025
- 200 Pages
Global
From €2484EUR$2,789USD£2,166GBP
- Drug Pipelines
- June 2025
- 200 Pages
Global
From €2484EUR$2,789USD£2,166GBP
- Drug Pipelines
- June 2025
- 200 Pages
Global
From €2484EUR$2,789USD£2,166GBP
- Drug Pipelines
- June 2025
- 200 Pages
Global
From €2484EUR$2,789USD£2,166GBP
- Drug Pipelines
- June 2025
- 200 Pages
Global
From €2484EUR$2,789USD£2,166GBP
- Report
- June 2025
- 150 Pages
Global
From €2404EUR$2,699USD£2,096GBP
- Report
- June 2025
- 150 Pages
Global
From €2404EUR$2,699USD£2,096GBP
- Report
- June 2025
- 400 Pages
Global
From €4407EUR$4,949USD£3,843GBP
- Report
- March 2026
- 149 Pages
Global
From €3561EUR$3,999USD£3,105GBP

The insulin market is a subset of the larger endocrine and metabolic disorders drugs market. Insulin is a hormone produced by the pancreas that helps regulate the body's blood sugar levels. It is used to treat diabetes, a condition in which the body does not produce enough insulin or is unable to use it effectively. Insulin is available in both short-acting and long-acting forms, and is typically administered via injection or an insulin pump.
The insulin market is highly competitive, with a number of major pharmaceutical companies offering a variety of insulin products. These include Eli Lilly, Novo Nordisk, Sanofi, and Merck. Additionally, there are a number of smaller companies that specialize in the production of insulin, such as Biocon, Wockhardt, and Wockhardt USA. Show Less Read more